May | 2015 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group | Page 4
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours - ScienceDirect